The Philippines and Novavax will sign a supply deal for 30 million COVID-19 shots on March 10.
Malacañang on Tuesday said that the Philippines and Novavax will sign a supply deal that would cover 30 million COVID-19 shots on March 10, 2021.
According to Presidential spokesperson Harry Roque, the said agreement would cover 30 million Novavax COVID-19 vaccine doses. Roque also said that they can’t yet disclose how much would be spent for the procurement of the said vaccines until the deal was signed.
“Pipirmahan na rin bukas, ika-10 ng Marso ang supply agreement with Novavax, 30 million po iyan,” Roque said.
Meanwhile, the chief executive of Novavax Inc. on Monday said that its vaccine could be cleared for emergency use in the United States as soon as May 2021 if United States regulators authorized it based on data from the company’s UK trial, which could be completed as soon as April 2021.
Chief Executive Stanley Erck said that Novavax can already manufacture its shots at scale and would be able to have tens of millions of COVID-19 vaccine doses stockpiled and ready to ship in the US when it received an emergency use authorization (EUA).
“It will be substantial — in the many tens of millions or a hundred million,” Stanley Erck said in an interview.
READ ALSO | Locsin: 30M Novavax COVID-19 Vaccine Doses Assured To PH
An early data readout from its British trial in January showed the COVID-19 vaccine to be around 96% effective against the original version of COVID-19 and around 86% effective against the widely-circulating COVID-19 variant first discovered in the UK.
The Philippines had received 600,000 COVID-19 vaccine doses from Sinovac Biotech through a donation by the Chinese government, and 525,600 COVID-19 vaccine doses from AstraZeneca through COVAX Facility.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via our official Facebook page and YouTube channel.
